Siemens collaborates with CHD task force
In collaboration with the International Task Force for Prevention of Coronary Heart Disease, Siemens Medical Solutions introduced a refined method for the assessment of a patient's risk for coronary heart disease (CHD).

The method consists of the combined use of the Prospective Cardiovascular Muenster (PROCAM) calculator and a multislice CT examination of the heart to identify individuals at high risk for a future coronary event, according to their PROCAM score.

Using the PROCAM score, the population can be divided into three risk groups based on the risk in percent of myocardial infarction or sudden coronary death in 10 years. More than 20 percent is considered high-risk, 10 to 20 percent is considered intermediate risk and less than 10 percent is considered low to moderate risk, respectively.

Siemens Medical Solutions also is developing new features for its KinetDx Solutions Network.

One feature in the works-in-progress 4.0 release would allow physicians and sonographers to create patient reports utilizing an evidence-based method of diagnosis, in addition to new report upload file formats, and cardiac measurement transfer capabilities for the Acuson Cypress cardiovascular system.

The KinetDx Solutions 4.0 also is expected to allow physicians to upload final reports to a hospital information system (HIS) or cardiology information system (CIS) using a variety of new report formats, helping some cardiology departments eliminate the need for a previously required interface device or broker.